IDiyas

For the Inventor, By the Inventor

Boston, MA, United States of America

Hasnain Ahmed Malik

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 11.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:

goldMedal7 out of 3,923 
 
Novartis Ag
 patents

Years Active: 2019-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):
1. 12252482 - Pyrazolopyridine derivatives and uses thereof (2025-03-18),
2. 12172984 - Pyrazolopyridine derivatives and uses thereof (2024-12-24),
3. 11787785 - Pyrazolopyridine derivatives and uses thereof (2023-10-17),
4. 11566022 - 3-(5-methoxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof (2023-01-31),
5. 11192877 - 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof (2021-12-07),
6. 11066369 - N-(pyridin-2-yl)pyridine-sulfonamide derivatives and their use in the treatment of disease (2021-07-20),
7. 10450273 - N-(pyridin-2-yl)pyridine-sulfonamide derivatives and their use in the treatment of disease (2019-10-22),

Title: Innovations of Hasnain Ahmed Malik

Introduction

Hasnain Ahmed Malik is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for inherited blood disorders. With a total of 7 patents to his name, Malik's work is recognized for its potential impact on medical science.

Latest Patents

Among his latest patents are the Pyrazolopyridine derivatives and their uses. These compounds are designed to reduce the expression levels of Widely Interspaced Zinc Finger Motifs (WIZ) and induce fetal hemoglobin (HbF) expression. This innovation holds promise for the treatment of inherited blood disorders, including sickle cell disease and beta-thalassemia.

Career Highlights

Hasnain Ahmed Malik is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on groundbreaking research and development in the pharmaceutical sector. His contributions have been instrumental in advancing therapeutic options for patients suffering from serious blood disorders.

Collaborations

Malik collaborates with talented professionals in his field, including Simone Bonazzi and Artiom Cernijenko. These collaborations enhance the innovative potential of his research and contribute to the overall success of their projects.

Conclusion

Hasnain Ahmed Malik's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and research efforts are paving the way for new treatments that could significantly improve the lives of individuals with inherited blood disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…